Metraipolis › archive › dc_a277e3542e01

Advances in β-Thalassemia Gene Therapy: CRISPR/Cas Systems and Delivery Innovations — Europe PMC PMID:41148810

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41148810
DOI
10.3390/cells14201595
License (as archived)
solo-consultazione
Archived
2026-11-09T08:51:00.677Z
SHA-256 of the archived text
272a4f6a2dcbb9842d8c68e8d7281d50bda631b453ab7b7dcae1e3518fc0677b
Stable URL of this page
https://metraipolis.com/documento/dc_a277e3542e01

How to cite

Advances in β-Thalassemia Gene Therapy: CRISPR/Cas Systems and Delivery Innovations — Europe PMC PMID:41148810 — Europe PMC (en), https://europepmc.org/article/MED/41148810 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a277e3542e01 (Metraipolis archive dc_a277e3542e01, sha256 272a4f6a2dcbb9842d8c68e8d7281d50bda631b453ab7b7dcae1e3518fc0677b)
BibTeX
@misc{dca277e3542e01,
  title = {Advances in β-Thalassemia Gene Therapy: CRISPR/Cas Systems and Delivery Innovations — Europe PMC PMID:41148810},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41148810},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a277e3542e01; sha256 272a4f6a2dcbb9842d8c68e8d7281d50bda631b453ab7b7dcae1e3518fc0677b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41148810. Agents can read the archived copy with the MCP tool read_document.